You have 9 free searches left this month | for more free features.

Surgical GBM

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors

Recruiting
  • Glioblastoma Multiforme
  • Surgical removal of the GBM tumor
  • d4-NAM infusion
  • Orlando, Florida
    AdventHealth Translational Research Institute
Sep 20, 2023

Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

Recruiting
  • Glioma, Malignant
  • +6 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 13, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

Not yet recruiting
  • Glioblastoma
  • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
  • (no location specified)
Apr 20, 2022

Glioblastoma, Glioblastoma Multiforme, GBM Trial in New York (Tissue autograft of pedicled temporoparietal fascial (TPF) or

Recruiting
  • Glioblastoma
  • +3 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)

Recruiting
  • Recurrent Glioblastoma
  • Glioblastoma - Category
  • Repeat Surgical Management of Recurrent GBM
  • Edmonton, Alberta, Canada
    University of Alberta Division of Neurosurgery
Apr 5, 2022

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)

Recruiting
  • Glioblastoma
  • +2 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jul 16, 2021

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,

Withdrawn
  • Recurrent Glioblastoma
  • +3 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 10, 2021

Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)

Active, not recruiting
  • Glioblastoma Multiforme
  • Anaplastic Glioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 29, 2020

Brain and CNS Tumors Trial in United States (biological, drug, procedure)

Completed
  • Brain and Central Nervous System Tumors
  • HSPPC-96
  • +2 more
  • San Francisco, California
  • +8 more
Mar 23, 2021

Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

Not yet recruiting
  • Glioblastoma
  • Amyvid, Intravenous Solution
  • Bayamon, Puerto Rico
  • +1 more
Apr 18, 2023

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)

Recruiting
  • GBM
  • Postoperative radiotherapy for SVZ
  • Nanjing, Jiangsu, China
    Lining Guo
Oct 14, 2023

[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Positron Emission Tomography-Computerised Tomography (PET-CT)
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Mar 23, 2023

Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity

Recruiting
  • Glioblastoma
  • radiation of brain tissue specimen and dna damage analysis
  • Rozzano, Milan, Italy
    Humanitas Clinical Institute
Oct 4, 2022

IRD at Admission Predicts Survival of GBM Patients -Prospective

Recruiting
  • Glioblastoma Multiforme
    • Winnipeg MB, Manitoba, Canada
    • +1 more
    Jun 8, 2022

    Glioblastoma Trial in Morgantown (Daratumumab)

    Recruiting
    • Glioblastoma
    • Morgantown, West Virginia
      West Virginia University Cancer Institute Mary Babb Randolph Can
    Dec 5, 2022

    Glioblastoma Trial in Boston (ITI-1001)

    Not yet recruiting
    • Glioblastoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 13, 2023

    Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

    Recruiting
    • Glioblastoma Multiforme
    • Recurrent Glioblastoma
    • TheraSphere GBM
    • San Francisco, California
    • +4 more
    Aug 15, 2022

    Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

    Recruiting
    • Glioblastoma, Adult
    • Pembrolizumab at 7 days prior
    • +3 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

    Recruiting
    • Glioblastoma (GBM)
    • Advanced diffusion-weighted MRI (ADW-MRI)
    • Basel, Switzerland
      University Hospital Basel
    Jun 21, 2023

    Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

    Active, not recruiting
    • Glioblastoma, Adult
    • Paxalisib (GDC-0084)
    • Los Angeles, California
    • +5 more
    Aug 16, 2022

    Glioblastoma Trial in Toronto (Focused Ultrasound (FUS) BBB Disruption)

    Active, not recruiting
    • Glioblastoma
    • Focused Ultrasound (FUS) BBB Disruption
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Mar 28, 2022

    Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)

    Recruiting
    • Glioblastoma Multiforme
    • Dichloroacetate (DCA)
    • Genotype
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Aug 26, 2022